NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis

Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation of therapies to be made available on the NHS that help treat the underlying cause […]

Read More  on the NHS website.